The molecular epidemiology of multidrug-resistant Acinetobacter baumannii was
investigated in the medical-surgical intensive care unit (ICU) of a university hospital in Italy …

Acinetobacter baumannii is the most common nosocomial pathogen among all
Acinetobacter spp. A. baumannii tend to be resistant to multiple antibiotics, and represent a …

The mechanism of stepwise acquired multidrug resistance in Acinetobacter baumannii
isolates from a hospitalized patient was investigated. Thirteen consecutive multidrug …

Over the last three decades, Acinetobacter has gained importance as a leading nosocomial
pathogen, partly due to its impressive genetic capabilities to acquire resistance and partly …

Acinetobacter baumannii is recognized as an emerging bacterial pathogen because of traits
such as prolonged survival in a desiccated state, effective nosocomial transmission, and an …

Multidrug-resistant (MDR) Acinetobacter baumannii infections are of particular concern
within medical treatment facilities, yet the gene assemblages that give rise to this phenotype …

Acinetobacter baumannii (A. baumannii) is undoubtedly one of the most successful
pathogens in the modern healthcare system. With invasive procedures, antibiotic use and …

Acinetobacter baumannii is an opportunistic pathogen, especially in intensive care units,
and multidrug-resistant isolates have increasingly been reported during the last decade …

The gram-negative coccobacillus acinetobacter, a pathogen once seen only in hot, humid
climates, has become an increasingly common nosocomial problem even in temperate …

Antibiotic resistance in Acinetobacter spp., particularly Acinetobacter baumannii, is
increasing rapidly. A. baumannii possesses two intrinsic β‐lactamase genes, in addition to …